The modified Makari skin test in urology--is it significant?
The Makari test is able to detect the presence of cancer in 95% of patients with primary tumours having excluded anergic patients. The test is useful in monitoring primary treatment. A long-term follow-up is necessary to determine the reason for patients' unexplained positive reactions in a control group of patients.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D011379:Prognosis; D012882:Skin Tests; D014571:Urologic Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy